Buchumschlag

Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting: from clinical trials to daily practice

Chemotherapy-induced nausea and vomiting (CINV) is a common adverse event associated - with many anticancer therapies and can negatively impact patients' quality of life and potentially - limit the effectiveness of chemotherapy. Currently, CINV can be prevented in most patients with - guideline...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Aapro, Matti S. (VerfasserIn) , Jordan, Karin (VerfasserIn) , Scotté, Florian (VerfasserIn) , Celio, Luigi (VerfasserIn) , Karthaus, Meinolf (VerfasserIn) , Roeland, Eric (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 18 July, 2022
In: Current cancer drug targets
Year: 2022, Jahrgang: 22, Heft: 10, Pages: 806-824
ISSN:1873-5576
DOI:10.2174/1568009622666220513094352
Online-Zugang:Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.2174/1568009622666220513094352
Verlag, lizenzpflichtig, Volltext: https://www.eurekaselect.com/article/123486
Volltext
Verfasserangaben:Matti Aapro, Karin Jordan, Florian Scotté, Luigi Celio, Meinolf Karthaus and Eric Roeland

MARC

LEADER 00000caa a2200000 c 4500
001 1830650947
003 DE-627
005 20230427151633.0
007 cr uuu---uuuuu
008 230110s2022 xx |||||o 00| ||eng c
024 7 |a 10.2174/1568009622666220513094352  |2 doi 
035 |a (DE-627)1830650947 
035 |a (DE-599)KXP1830650947 
035 |a (OCoLC)1361669776 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Aapro, Matti S.  |d 1951-  |e VerfasserIn  |0 (DE-588)172799430  |0 (DE-627)697729990  |0 (DE-576)133655865  |4 aut 
245 1 0 |a Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting  |b from clinical trials to daily practice  |c Matti Aapro, Karin Jordan, Florian Scotté, Luigi Celio, Meinolf Karthaus and Eric Roeland 
264 1 |c 18 July, 2022 
300 |a 19 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 10.01.2023 
520 |a Chemotherapy-induced nausea and vomiting (CINV) is a common adverse event associated - with many anticancer therapies and can negatively impact patients' quality of life and potentially - limit the effectiveness of chemotherapy. Currently, CINV can be prevented in most patients with - guideline-recommended antiemetic regimens. However, clinicians do not always follow guidelines, - and patients often face difficulties adhering to their prescribed treatments. Therefore, approaches to - increase guideline adherence need to be implemented. 
700 1 |a Jordan, Karin  |d 1974-  |e VerfasserIn  |0 (DE-588)123243327  |0 (DE-627)706224078  |0 (DE-576)293619174  |4 aut 
700 1 |a Scotté, Florian  |e VerfasserIn  |4 aut 
700 1 |a Celio, Luigi  |e VerfasserIn  |4 aut 
700 1 |a Karthaus, Meinolf  |e VerfasserIn  |4 aut 
700 1 |a Roeland, Eric  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t Current cancer drug targets  |d Hilversum [u.a.] : Bentham Science Publ., 2001  |g 22(2022), 10, Seite 806-824  |h Online-Ressource  |w (DE-627)362755582  |w (DE-600)2099324-9  |w (DE-576)273874209  |x 1873-5576  |7 nnas  |a Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting from clinical trials to daily practice 
773 1 8 |g volume:22  |g year:2022  |g number:10  |g pages:806-824  |g extent:19  |a Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting from clinical trials to daily practice 
856 4 0 |u https://doi.org/10.2174/1568009622666220513094352  |x Resolving-System  |x Verlag  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.eurekaselect.com/article/123486  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20230110 
993 |a Article 
994 |a 2022 
998 |g 123243327  |a Jordan, Karin  |m 123243327:Jordan, Karin  |d 50000  |e 50000PJ123243327  |k 0/50000/  |p 2 
999 |a KXP-PPN1830650947  |e 4245681667 
BIB |a Y 
SER |a journal 
JSO |a {"origin":[{"dateIssuedKey":"2022","dateIssuedDisp":"18 July, 2022"}],"id":{"doi":["10.2174/1568009622666220513094352"],"eki":["1830650947"]},"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"relHost":[{"disp":"Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting from clinical trials to daily practiceCurrent cancer drug targets","pubHistory":["1.2001 -"],"recId":"362755582","note":["Gesehen am 09.04.24"],"type":{"bibl":"periodical","media":"Online-Ressource"},"id":{"zdb":["2099324-9"],"issn":["1873-5576"],"eki":["362755582"]},"language":["eng"],"origin":[{"dateIssuedDisp":"2001-","publisherPlace":"Hilversum [u.a.]","publisher":"Bentham Science Publ.","dateIssuedKey":"2001"}],"part":{"text":"22(2022), 10, Seite 806-824","pages":"806-824","volume":"22","issue":"10","extent":"19","year":"2022"},"title":[{"title_sort":"Current cancer drug targets","title":"Current cancer drug targets"}],"physDesc":[{"extent":"Online-Ressource"}]}],"person":[{"given":"Matti S.","family":"Aapro","display":"Aapro, Matti S.","role":"aut"},{"role":"aut","display":"Jordan, Karin","family":"Jordan","given":"Karin"},{"display":"Scotté, Florian","family":"Scotté","given":"Florian","role":"aut"},{"given":"Luigi","display":"Celio, Luigi","family":"Celio","role":"aut"},{"role":"aut","family":"Karthaus","display":"Karthaus, Meinolf","given":"Meinolf"},{"given":"Eric","family":"Roeland","display":"Roeland, Eric","role":"aut"}],"title":[{"subtitle":"from clinical trials to daily practice","title":"Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting","title_sort":"Netupitant-palonosetron (NEPA) for preventing chemotherapy-induced nausea and vomiting"}],"physDesc":[{"extent":"19 S."}],"recId":"1830650947","note":["Gesehen am 10.01.2023"],"name":{"displayForm":["Matti Aapro, Karin Jordan, Florian Scotté, Luigi Celio, Meinolf Karthaus and Eric Roeland"]}} 
SRT |a AAPROMATTINETUPITANT1820 

Ähnliche Einträge